The renin-angiotensin system: A potential modulator of endothelial progenitor cells

Hypertension Research

Volumn 30, Issue 11, 2007, Pages 1017-1018

  Fukuda, Daiju ^a   Sata, Masataka ^a  

^a UNIVERSITY OF TOKYO   (Japan)

Author keywords

Angiogenesis; Angiotensin II; Endothelial progenitor cells; Ischemia; Oxidative stress

Indexed keywords

ALDOSTERONE; ANGIOTENSIN; ANGIOTENSIN II; ANGIOTENSIN RECEPTOR ANTAGONIST; ESTROGEN; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; LOSARTAN; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE 2; RENIN; RENIN INHIBITOR;

ANGIOGENESIS; BLOOD PRESSURE REGULATION; BLOOD VESSEL INJURY; CARDIOVASCULAR RISK; CELL AGING; CELL COUNT; CELL DIFFERENTIATION; CELL FUNCTION; CELL PROLIFERATION; CELL RENEWAL; EDITORIAL; ENDOTHELIUM CELL; HUMAN; HYPERTENSION; ISCHEMIC HEART DISEASE; MOLECULAR MECHANICS; NON INSULIN DEPENDENT DIABETES MELLITUS; OXIDATION REDUCTION STATE; OXIDATIVE STRESS; PHYSICAL ACTIVITY; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; RISK FACTOR; SPONTANEOUSLY HYPERTENSIVE RAT; STEM CELL; STEM CELL MOBILIZATION; STEM CELL TRANSPLANTATION;

ENDOTHELIUM, VASCULAR; HUMANS; HYPERTENSION; LOSARTAN; NEOVASCULARIZATION, PATHOLOGIC; RENIN-ANGIOTENSIN SYSTEM; STEM CELLS;

EID: 37849003822     PISSN: 09169636     EISSN: 13484214     Source Type: Journal    
DOI: 10.1291/hypres.30.1017     Document Type: Editorial

References (17)

1. Sata M: Role of circulating vascular progenitors in angiogenesis, vascular healing, and pulmonary hypertension: lessons from animal models. Arterioscler Thromb Vasc Biol 2006; 26: 1008-1014.
2. Sata M, Saiura A, Kunisato A, et al: Hematopoietic stem cells differentiate into vascular cells that participate in the pathogenesis of atherosclerosis. Nat Med 2002; 8: 403-409.
3. Hill JM, Zalos G, Halcox JP, et al: Circulating endothelial progenitor cells, vascular function, and cardiovascular risk. N Engl J Med 2003; 348: 593-600.
4. Dimmeler S, Aicher A, Vasa M, et al: HMG-CoA reductase inhibitors (statins) increase endothelial progenitor cells via the PI 3-kinase/Akt pathway. J Clin Invest 2001; 108: 391-397.
5. Strehlow K, Werner N, Berweiler J, et al: Estrogen increases bone marrow-derived endothelial progenitor cell production and diminishes neointima formation. Circulation 2003; 107: 3059-3065.
6. Laufs U, Werner N, Link A, et al: Physical training increases endothelial progenitor cells, inhibits neointima formation, and enhances angiogenesis. Circulation 2004; 109: 220-226.
7. Yao E-H, Fukuda N, Matsumoto T, et al: Losartan improves the impaired function of endothelial progenitor cells in hypertension via an antioxidant effect. Hypertens Res 2007; 30: 1119-1128.
8. Imanishi T, Hano T, Nishio I: Angiotensin II accelerates endothelial progenitor cell senescence through induction of oxidative stress. J Hypertens 2005; 23: 97-104.
9. Bahlmann FH, de Groot K, Mueller O, Hertel B, Haller H, Fliser D: Stimulation of endothelial progenitor cells: a new putative therapeutic effect of angiotensin II receptor antagonists. Hypertension 2005; 45: 526-529.
10. Paul M, Poyan Mehr A, Kreutz R: Physiology of local renin-angiotensin systems. Physiol Rev 2006; 86: 747-803.
11. Haznedaroglu IC, Ozturk MA: Towards the understanding of the local hematopoietic bone marrow renin-angiotensin system. Int J Biochem Cell Biol 2003; 35: 867-880.
12. Rodgers KE, Xiong S, Steer R, diZerega GS: Effect of angiotensin II on hematopoietic progenitor cell proliferation. Stem Cells 2000; 18: 287-294.
13. Sasaki K, Murohara T, Ikeda H, et al: Evidence for the importance of angiotensin II type 1 receptor in ischemia-induced angiogenesis. J Clin Invest 2002; 109: 603-611.
14. Egami K, Murohara T, Shimada T, et al: Role of host angiotensin II type 1 receptor in tumor angiogenesis and growth. J Clin Invest 2003; 112: 67-75.
15. Noble M, Smith J, Power J, Mayer-Proschel M: Redox state as a central modulator of precursor cell function. Ann N Y Acad Sci 2003; 991: 251-271.
16. + stem cells for intractable angina: a phase I/IIa double-blind, randomized controlled trial. Circulation 2007; 115: 3165-3172.
17. Hristov M, Weber C: The therapeutic potential of progenitor cells in ischemic heart disease - past, present and future. Basic Res Cardiol 2006; 101: 1-7.